10 February 2017
Lewin v Glaxo Operations UK Ltd (sued as Glaxosmithkline Unlimited) [2016] EWHC 3331 (QB), [2016] All ER (D) 122 (Dec)
The Queen’s Bench Division held that the claimant’s negligence proceedings against the defendant for personal injuries and consequential loss arising out of his exposure to Myodil in 1973 had been brought within the statutory limitation period. Although there could be no precision as to timing, the damage had probably been caused shortly before or in 2007 and the cause of action had arisen when the claimant had been diagnosed as suffering from post-Myodil adhesive arachnoiditis.
